Guidelines for follow-up in cervical cancer
| Cervical cancer | Clinic-based follow-up | Telephone follow-up ± blood test | PIFU |
| Low risk (<10% ROR) excluding fertility sparing surgery/LLETZ | For 5 years post-completion of treatment | Not suitable | Offer from 2 years from end of treatment |
| Intermediate risk | For 5 years post-completion of treatment | Not suitable | Not suitable |
| High risk | For 5 years post-completion of treatment | Not suitable | Not suitable |
LLETZ, large loop excision of transformation zone; PIFU, patient-initiated follow-up; ROR, risk of recurrence.